University of Sharjah

Dozee coming up with AI-powered ECG patch for remote cardiac monitoring Indian medical device maker Dozee is introducing a new ECG patch device to its portfolio of remote monitoring solutions. According to a press release, the ECG patch monitors the heart's electrical activity continuously over multiple days. It will help detect arrhythmias and other early signs of cardiac deterioration, assisting clinicians in providing timely medical interventions. This device can also feed live and continuous ECG data via the cloud and provide alerts to doctors. "We are excited to enter the cardiac monitoring segment in India with our ECG patch, which is an addition to our vitals monitoring portfolio. This technology can be especially pivotal in India, as cardiovascular disease has become the leading cause of morbidity and mortality over the last three decades," said Dozee CEO and co-founder Mudit Dandwate. India reports up to 1.8 million new cardiac cases each year, becoming a fast-growing disease burden in the country. Philips launches AR surgical navigation tool ClarifEye in Japan An augmented reality surgical navigation solution by Royal Philips has come to Japan. Called ClarifEye, the solution combines 2D and 3D visualizations at low x-ray doses with 3D AR navigation into one system. It enables surgeons to define and navigate critical trajectories for precise device placement while avoiding damage to neurological and vascular structures close to the patient’s spine. Philips reported its first use case in Japan in a hybrid OR at the International University of Health and Welfare, Mita Hospital. "The addition of a new navigation system helps to create an even safer surgical environment. Compared to existing navigation systems, ClarifEye has no reference frame-related errors, and it’s wonderful that it achieves real-time imaging with pedicle segmentation," Dr Ken Ishi of the hospital's Department of Orthopedic Surgery commented. Connect2MyDoctor signs research pact with the University of Sharjah India-based telehealth platform Connect2MyDoctor has signed a memorandum of understanding with the University of Sharjah in the United Arab Emirates to collaborate on research activities. As part of the deal, they will develop rehabilitation and well-being initiatives, leveraging C2MD's integrated care coach OmniROM, which enables remote monitoring and measuring of a patient’s recovery or rehabilitation via video consultation. Their collaboration may also extend to areas such as data collection, analysis and joint submissions to journals, conferences and other scientific venues. Another key aspect of this partnership is its contribution to local health development, said Prof Mohamad Alameddine, dean of the College of Health Sciences at the University of Sharjah. Additionally, C2MD has opened a regional headquarters in Dubai, further solidifying its presence in the UAE. It has recently signed two clients in Bahrain – Ithmaar Bank and Royal Hospital for Women and Children – and has a tie-up with the Federal Authority of Human Resources to provide access to online mental health care to around 100,000 employees and their families. Taiwan OKs VUNO's bone age analysis software VUNO has received the approval of the Taiwan FDA for its bone age analysis software. VUNO Med Bone Age automatically assesses bone age by reading a hand x-ray. The company will begin commercialising the software in Taiwan through its exclusive distributor contract with the CHC Healthcare Group.

P&G Health commemorated World Pharmacists Day 2022 across the Asia Pacific, Middle East, and Africa region through a host of activities This includes the first ever P&G Health Middle-East Whole-Body Health Symposium over 2 days in which 12,813 participants from 111 countries took part SINGAPORE, Sept. 26, 2022 /PRNewswire/ -- P&G Health ( NYSE:PG) commemorated World Pharmacists Day 2022 across Asia Pacific, Middle East, and Africa, lauding the integral role pharmacists play in overall healthcare and quality of life of patients. With the theme of "Pharmacy united in action for a healthier world" for this year's World Pharmacists Day, it spotlighted their role in improving health outcomes by providing counsel on daily self-care habits, timely diagnoses, education, and management. Continue Reading image1 The commemoration of World Pharmacists Day 2022 was organized through various activities to build on P&G's existing relationships with pharmacists and their associations. A marquee activity was the 2-day P&G Health Middle-East Whole-Body Health Symposium which was organized for the first time by Centre for Advanced Professional Practices (CAPP) in the format of a virtual, professionally accredited symposium. The symposium agenda covered a range of topics including Oral and General Health, Maternal Health, and Non-Communicable Diseases. The interactive, virtual sessions highlighted the role of pharmacists within the holistic health journey and presented actionable updates pharmacists need to stay informed, deliver optimal care, and improve quality of life of consumers. Attended by 4514 pharmacists from across the Middle East, P&G Health also invited pharmacists from outside the region to take part. Dr Ashley Barlow, Senior Director, Medical & Technical Affairs, P&G Health – Asia Pacific, India, Middle East, and Africa said: "At P&G Health, we believe in creating collaborative ecosystems with key partners such as pharmacists to help patients with their medical and healthcare needs. By recognising the role, they play in creating awareness, better education, and providing guidance, it will go a long way to ensure we can provide whole-of-body healthcare to patients. With growth opportunities in consumer health and wellness segments, P&G Health is demonstrating through focused and continued innovation how unlocking the power of well-informed health professionals can facilitate 'Total Body Health' in the region and beyond." Assoc. Prof Nadia Al Mazrouei, Pharmacy Practice and Pharmacotherapeutics, Sharjah University and a speaker moderator at the summit said: "As healthcare systems continue to evolve, consumers have a heightened awareness of self-care. Pharmacists play a crucial role in the ongoing holistic health revolution as go-to resources for consumers to gain information and develop an understanding of complex conditions. We are pleased to partner with P&G Health to facilitate better healthcare outcomes and foster equity across diverse communities in the region and raise awareness of the role of pharmacists within holistic healthcare." For more information about P&G Health's initiatives for pharmacists, please visit . About P&G Health: P&G Health, the health care division of P&G company, drives consumer-centric innovation to empower our consumers to live longer, healthier, and more vibrant lives. The P&G Health portfolio includes leading brands in Respiratory with Vicks® and Nasivin®, Pregnancy with Femibion® and Clearblue®, Oral Care with Crest® and Oral-B®, Vitamins and Minerals Supplementation with Bion3®, Seven Seas®, Evion® and Sangobion®, Digestive wellness with Metamucil®, Prilosec OTC®, Pepto Bismol® and Align®, Nerve Care with Neurobion® and Pain Relief with Dolo-Neurobion®. About Procter & Gamble: P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Photo - SOURCE Procter and Gamble